Literature DB >> 34896767

The antimicrobial and immunomodulatory effects of Ionophores for the treatment of human infection.

Gen Li1, David M P De Oliveira1, Mark J Walker2.   

Abstract

Ionophores are a diverse class of synthetic and naturally occurring ion transporter compounds which demonstrate both direct and in-direct antimicrobial properties against a broad panel of bacterial, fungal, viral and parasitic pathogens. In addition, ionophores can regulate the host-immune response during communicable and non-communicable disease states. Although the clinical use of ionophores such as Amphotericin B, Bedaquiline and Ivermectin highlight the utility of ionophores in modern medicine, for many other ionophore compounds issues surrounding toxicity, bioavailability or lack of in vivo efficacy studies have hindered clinical development. The antimicrobial and immunomodulating properties of a range of compounds with characteristics of ionophores remain largely unexplored. As such, ionophores remain a latent therapeutic avenue to address both the global burden of antimicrobial resistance, and the unmet clinical need for new antimicrobial therapies. This review will provide an overview of the broad-spectrum antimicrobial and immunomodulatory properties of ionophores, and their potential uses in clinical medicine for combatting infection.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteria; Fungi; Immunomodulator; Ionophore; Parasite; Virus

Mesh:

Substances:

Year:  2021        PMID: 34896767     DOI: 10.1016/j.jinorgbio.2021.111661

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  4 in total

Review 1.  Ion Channels and Transporters as Therapeutic Agents: From Biomolecules to Supramolecular Medicinal Chemistry.

Authors:  Giacomo Picci; Silvia Marchesan; Claudia Caltagirone
Journal:  Biomedicines       Date:  2022-04-12

2.  Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives.

Authors:  Dimitrios Fotis; Junli Liu; Maria Dalamaga
Journal:  Metabol Open       Date:  2022-03-14

3.  Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication.

Authors:  Jerneja Kladnik; Ana Dolinar; Jakob Kljun; David Perea; Judith Grau-Expósito; Meritxell Genescà; Marko Novinec; Maria J Buzon; Iztok Turel
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 4.  Evidence of Metallic and Polyether Ionophores as Potent Therapeutic Drug Candidate in Cancer Management.

Authors:  Pratibha Pandey; Fahad Khan; Huda A Qari; Tarun Kumar Upadhyay; Abdulhameed F Alkhateeb; Mohammad Oves
Journal:  Molecules       Date:  2022-07-23       Impact factor: 4.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.